New paper by EdgeLeap team!

A new paper by the EdgeLeap team is now online. In this paper we demonstrate how linking high-throughput molecular data with physiological parameters enables discovery of biomarkers and novel therapeutic targets. We identified and prioritized sets of key nodes in hepatic molecular networks underlying type 2 diabetes mellitus and discovered mechanisms that are critical to target by anti-diabetic interventions to steer the complex disease phenotype.

Read the paper here!